Cardiovascular effects of constant rate infusions of lidocaine, lidocaine and dexmedetomidine, and dexmedetomidine in dogs anesthetized at equipotent doses of sevoflurane
- PMID: 28698692
- PMCID: PMC5479674
Cardiovascular effects of constant rate infusions of lidocaine, lidocaine and dexmedetomidine, and dexmedetomidine in dogs anesthetized at equipotent doses of sevoflurane
Abstract
This study evaluated the cardiovascular effects of a constant rate infusion (CRI) of lidocaine, lidocaine and dexmedetomidine, and dexmedetomidine in dogs anesthetized with sevoflurane at equipotent doses. Treatments consisted of T1-Lidocaine [loading dose 2 mg/kg body weight (BW), IV, and CRI of 100 μg/kg BW per min] at 1.4% end-tidal of sevoflurane (FESEV); T2-Dexmedetomidine (loading dose 2 μg/kg BW, IV, and CRI of 2 μg/kg BW per hour) and FESEV 1.1%; and T3-Lidocaine-Dexmedetomidine using the same doses of T1 and T2 and FESEV 0.8%. Constant rate infusion of lidocaine did not induce any cardiovascular changes; lidocaine and dexmedetomidine resulted in cardiovascular effects similar to dexmedetomidine alone. These effects were characterized by a significant (P < 0.001) decrease in heart rate, cardiac output, cardiac index, oxygen delivery, and pulmonary vascular resistance index, and a significant (P < 0.001) increase in mean and diastolic arterial pressure, systemic vascular resistance index, pulmonary arterial occlusion pressure and oxygen extraction ratio, compared with baseline values. In conclusion, a CRI of lidocaine combined with dexmedetomidine produces significant cardiovascular changes similar to those observed with dexmedetomidine alone.
Effets cardiovasculaires des infusions constante de taux de lidocaïne, lidocaïne et dexmédétomidine, et dexmédétomidine chez chiens anesthésier at équipotent doses de sevoflurane. L’objet de cette etude a été la evaluation des effets cardo-vasculaires de la perfusion à debit continue (CRI) de lidocaïne, lidocaïene et dexmédétomidine, et dexmédétomidine en chiens anesthésiés avec sévoflurane dans équipotentiel dose. Les traitemets consistèrent á T1-Lidocaïne [dose de charge de 2 mg/kg, IV, et perfusion à debit continue (CRI) de 100 μg/kg/min] en 1,4 % en fin d’expiration du sévoflurane (FESEV); T2-Déxmédetomidine (dose de charge de 2 μg/kg, IV, et perfusion à debit continue (CRI) de 2 μg/kg/h) et FESEV 1,1 % et T3-Lidocaïne-Dexmédétomidine en utilisant la même dose de T1 et T2 et FESEV 0,8 %. Perfusion à debit continue (CRI) de lidocaïne ne induit pas aucun échange cardio-vasculaire; lidocaïne et dexmédétomidine resulta dans effets cardio-vasculaires similaires a dexmédétomidine seule. Ces effets caracterices par significative décroissance (P < 0,001) en fréquence cardiaque, le débit cardiaque, index cardiaque, la libération de l’oxygène, pulmonaire indice de résistance vasculaire, et significative accroissement de la moyenne a la pression artériele diastolique (P < 0,001), indice de résistance vasculaire systémique, et l’extraction d’oxygène. En somme, la perfusion à debit continue (CRI) de lidocaïne produit significative échange cardio-vasculaire similaire à ceux observe en itilisant seulement dexmédétomidine.(Traduit par les auteurs).
Similar articles
-
Influence of intravenous fentanyl or dexmedetomidine infusions, combined with lidocaine and ketamine, on cardiovascular response, sevoflurane requirement and postoperative pain in dogs anesthetized for unilateral mastectomy.Vet Anaesth Analg. 2024 Jul-Aug;51(4):381-390. doi: 10.1016/j.vaa.2024.04.006. Epub 2024 Apr 18. Vet Anaesth Analg. 2024. PMID: 38744657
-
Effects of lidocaine, dexmedetomidine or their combination on the minimum alveolar concentration of sevoflurane in dogs.J Vet Med Sci. 2014 Jun;76(6):847-53. doi: 10.1292/jvms.13-0407. Epub 2014 Feb 27. J Vet Med Sci. 2014. PMID: 24572631 Free PMC article.
-
Nicardipine constant rate infusion alleviates the cardiovascular effects of dexmedetomidine infusions without affecting the minimal alveolar concentration in sevoflurane-anesthetized dogs.Res Vet Sci. 2024 Jun;172:105254. doi: 10.1016/j.rvsc.2024.105254. Epub 2024 Apr 2. Res Vet Sci. 2024. PMID: 38582048
-
Effects of dexmedetomidine on sevoflurane requirement for 50% excellent tracheal intubation in children: a randomized, double-blind comparison.Paediatr Anaesth. 2014 Sep;24(9):987-93. doi: 10.1111/pan.12430. Epub 2014 May 14. Paediatr Anaesth. 2014. PMID: 24823715 Review.
-
Retrospective study on the use of lidocaine constant rate infusions for the treatment of ileus in ruminants and camelids.J Vet Intern Med. 2021 Nov;35(6):2933-2936. doi: 10.1111/jvim.16262. Epub 2021 Sep 13. J Vet Intern Med. 2021. PMID: 34514646 Free PMC article. Review.
Cited by
-
Sparing effect of tramadol, lidocaine, dexmedetomidine and their combination on the minimum alveolar concentration of sevoflurane in dogs.J Vet Sci. 2022 Jul;23(4):e53. doi: 10.4142/jvs.21305. Epub 2022 May 9. J Vet Sci. 2022. PMID: 35698808 Free PMC article.
-
Cardiovascular and renal effects of constant rate infusions of remifentanil, dexmedetomidine and their combination in dogs anesthetized with sevoflurane.J Vet Med Sci. 2021 Mar 5;83(2):285-296. doi: 10.1292/jvms.20-0457. Epub 2020 Dec 11. J Vet Med Sci. 2021. PMID: 33310997 Free PMC article.
-
Effects of anesthetic and sedative agents on sympathetic nerve activity.Heart Rhythm. 2019 Dec;16(12):1875-1882. doi: 10.1016/j.hrthm.2019.06.017. Epub 2019 Jun 25. Heart Rhythm. 2019. PMID: 31252086 Free PMC article.
-
Antinociceptive and analgesic effect of continuous intravenous infusion of maropitant, lidocaine and ketamine alone or in combination in cats undergoing ovariohysterectomy.Acta Vet Scand. 2021 Nov 27;63(1):49. doi: 10.1186/s13028-021-00615-w. Acta Vet Scand. 2021. PMID: 34838084 Free PMC article.
-
Sevoflurane reduces cardiomyocyte injury in a hypoxia/reoxygenation model of cardiomyocytes through the linc01278/miR-134-5pt regulatory axis.BMC Pharmacol Toxicol. 2025 Apr 14;26(1):83. doi: 10.1186/s40360-025-00909-z. BMC Pharmacol Toxicol. 2025. PMID: 40229902 Free PMC article.
References
-
- Ilkiw JE. Balanced anesthetic techniques in dogs and cats. Clin Tech Small Anim Pract. 1999;14:27–37. - PubMed
-
- Pascoe PJ, Raekallio M, Kuusela E, McKusick B, Granholm M. Changes in the minimum alveolar concentration of isoflurane and some cardiopulmonary measurements during three continuous infusion rates of dexmedetomidine in dogs. Vet Anaesth Analg. 2006;33:97–103. - PubMed
-
- Gutierrez-Blanco E, Victoria-Mora JM, Ibancovichi-Camarillo JA, et al. Evaluation of the isoflurane-sparing effects of fentanyl, lidocaine, ketamine, dexmedetomidine, or the combination lidocaine-ketamine-dexmedetomidine during ovariohysterectomy in dogs. Vet Anaesth Analg. 2013;40:599–609. - PubMed
-
- Uilenreef JJ, Murrell JC, McKusick BC, Hellebrekers LJ. Dexmedetomidine continuous rate infusion during isoflurane anaesthesia in canine surgical patients. Vet Anaesth Analg. 2008;35:1–12. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources